Healthy Extracts Inc. has acquired Imaraïs Beauty, the fast-growing women’s wellness brand co-owned by fitness influencer Sommer Ray (pictured) and supplement executive Aaron Hefter, in a deal designed to catapult the company deeper into the booming ingestible beauty and functional wellness market.Imarais Beauty
The acquisition follows a recently announced manufacturing partnership between the two companies and signals a broader strategic push to combine celebrity-led brand building with proprietary delivery technology. Healthy Extracts says the combined business is projected to reach an annualized revenue run rate of roughly $24 million by the end of 2026, with revenues expected to surpass $55 million in 2027 as distribution scales globally.
For beauty insiders, the deal reflects several of the sector’s most important macro shifts converging at once: the continued premiumization of gummies, the growing overlap between OTC wellness and beauty positioning, and the increasing importance of creator-driven consumer acquisition. Imaraïs has already secured distribution with major retailers including Ulta Beauty, Target, Nordstrom and Sprouts Farmers Market, with a nationwide rollout into more than 4,400 CVS Pharmacy locations expected next month.
The acquisition also highlights how delivery technology is becoming a core point of differentiation in the crowded ingestible beauty space. Healthy Extracts is positioning its precision-dose gummy systems and future OTC capabilities as a competitive advantage at a time when brands are racing to elevate gummies beyond commodity collagen and biotin positioning into more clinically framed wellness platforms.
Sommer Ray, who brings a social audience exceeding 40 million followers, will remain with the company as chief innovation officer, while Hefter will become chief branding officer of Healthy Extracts and continue leading Imaraïs as president. Together, the companies say they aim to build a globally scaled women’s health and beauty gummy platform centered on taste, lifestyle integration and functional benefits.
The transaction arrives amid mounting consolidation pressure across the wellness and supplement landscape as investors increasingly view functional ingestibles as one of beauty’s most commercially attractive adjacent categories. With retail appetite for wellness gummies continuing to expand—particularly among younger consumers seeking convenient, sensory-first formats—the line separating beauty, supplements and OTC health products is rapidly disappearing.
Global Cosmetic Industry spoke with Aaron Hefter, founder and CEO, Imaraïs Beauty, and Duke Pitts, COO and president at Healthy Extracts, to learn more about the linkup between the companies.
On balancing celebrity-led velocity with precision-dose/IP strategy
Hefter and Pitts: The balance is exactly why the transaction is compelling. Imaraïs Beauty brings speed, culture, and consumer engagement. HYEX brings precision-dose thinking, formulation discipline, and scalable delivery systems. Our goal is to preserve the authenticity of the brand while strengthening the product platform behind it.
On near-term execution priorities for supply chain scalability
Hefter and Pitts: Near term, the priority is disciplined execution: production planning, ingredient availability, packaging, retailer compliance, inventory management, and on-time fulfillment. As distribution expands, we have to avoid chasing every opportunity at once. The focus is making sure the core SKUs are supported, retail partners are serviced properly, and global expansion is sequenced in a way the supply chain can handle.
On the key assumptions behind growth from ~$24M to $55M+ by 2027
Hefter and Pitts: The growth assumptions are based on three primary drivers: expanded retail distribution, stronger velocity within existing doors, and new product innovation. Retail expansion is the near-term driver, but product innovation and future wellness/OTC-adjacent opportunities are important to the longer-term growth curve. We are focused on building growth that is scalable, repeatable, and supported by operational execution—not just one-time distribution wins.
